Events, News, Presentations
21st Annual Needham Virtual Healthcare Conference – Presentation Download...
Events, News, Presentations, Press Releases
Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022 SOUTH SAN FRANCISCO, Calif., April 8, 2022 – Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development...
Events, News, Presentations
American Association for Cancer Research (AACR) Annual Meeting 2022 – Presentation Anti-FolRα ADC STRO-002 Induces Immunogenic Cell Death (ICD) to Enhance Anti-Tumor Activity Download Here Audio Presentation...
Events, News, Presentations, Press Releases
Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference SOUTH SAN FRANCISCO, Calif., April 5, 2022– Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company...
Events, News, Presentations, Press Releases
Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC SOUTH SAN FRANCISCO, Calif., March 30, 2022– Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug...
Events, News, Presentations
12th Annual World ADC London 2022 – Presentations World ADC 2022 presentation titled, “A New Molecular Class to target Tumor Immunity by both disrupting the tumor and enabling the immune system” presented by Trevor Hallam, Ph.D., President of Scientific and Chief...
